Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study.

Autor: Miri S; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy., Rosendaal FR; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands., Kavakli K; Ege Hemophilia Center, Pediatric Congenital Hematologic Disorders Research Center, Izmir, Türkiye., Eshghi P; Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Moghaddam SM; Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Scardo S; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy., Habibpanah B; Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Elalfy M; Department of Pediatric Hematology/Oncology, Ain Shams University, Cairo, Egypt., Halimeh S; Coagulation and Thrombosis Centre, Gerinnungszentrum Rhein Ruhr, Duisburg, Germany., Nicolò G; Department of Healthcare Professions, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy., Gökçebay D; Department of Pediatric Hematology/Oncology and Pediatric Bone Marrow Transplantation Unit, Ankara Bilkent City Hospital, Ankara, Türkiye., Özbek N; Department of Pediatric Hematology/Oncology and Pediatric Bone Marrow Transplantation Unit, Ankara Bilkent City Hospital, Ankara, Türkiye., Celkan T; Department of Pediatric Hematology and Oncology, Cerrahpaşa Faculty of Medicine, İstanbul University, Istanbul, Türkiye., Mohammadi A; Esfahan Hemophilia Treatment Centre, Seyed Shohada Hospital, Esfahan, Iran., Karimi M; Pediatric Hematology-Oncology Department, American Hospital Dubai, Dubai, United Arab Emirates.; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Shahsavani A; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Yılmaz B; Department of Pediatric Health and Diseases, Marmara University, Istanbul, Türkiye., Albayrak C; Department of Pediatric Hematology and Oncology BMT Unit, Ondokuz Mayıs University Faculty of Medicine, Samsun, Türkiye., Gunes B; İzmir Tepecik Training and Research Hospital, Clinic of Pediatric Hematology, İzmir, Türkiye., Kaya Z; Department of Pediatric Hematology, Gazi University Faculty of Medicine, Ankara, Türkiye., Ay Y; Department of Pediatric Hematology, Pamukkale University Faculty of Medicine, Denizli, Türkiye., Akbayram S; Department of Pediatric Hematology and Oncology BMT Unit, Gaziantep University Faculty of Medicine, Gaziantep, Türkiye., Sarper N; Department of Pediatric Hematology, Kocaeli University School of Medicine, Kocaeli, Türkiye., Mannucci PM; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy., Peyvandi F; Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

Publikováno v: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2024 Oct 18; Vol. 8 (8), pp. 102595. Date of Electronic Publication: 2024 Oct 18 (Print Publication: 2024).

Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.

Autor: Mohsenian S; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Palla R; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Menegatti M; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy., Cairo A; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy., Lecchi A; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy., Casini A; Division of Angiology and Hemostasis, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland., Neerman-Arbez M; Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Asselta R; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Milan, Italy., Scardo S; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy., Siboni SM; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy., Blatny J; Department of Paediatrics Haematology and Biochemistry, University Hospital Brno and Masaryk University, Brno, Czech Republic., Zapletal O; Department of Paediatrics Haematology and Biochemistry, University Hospital Brno and Masaryk University, Brno, Czech Republic., Schved JF; Department of Biological Hematology, CHU Montpellier, Université de Montpellier, Montpellier, France., Giansily-Blaizot M; Department of Biological Hematology, CHU Montpellier, Université de Montpellier, Montpellier, France., Halimeh S; Coagulation Centre Rhein-Ruhr, Duisburg, Germany., Daoud MA; Coagulation Centre Rhein-Ruhr, Duisburg, Germany., Platokouki H; Haemophilia-Centre-Haemostasis Unit, Aghia Sophia Children's Hospital, Athens, Greece., Pergantou H; Haemophilia-Centre-Haemostasis Unit, Aghia Sophia Children's Hospital, Athens, Greece., Schutgens REG; Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Van Haaften-Spoor M; Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Brons P; Department of Pediatric Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Laros-van Gorkom B; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Van Pinxten E; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Borhany M; Clinical Hematology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan., Fatima N; Clinical Hematology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan., Mikovic D; Hemostasis Department, Blood Transfusion Institute of Serbia, Belgrade, Serbia., Saracevic M; Hemostasis Department, Blood Transfusion Institute of Serbia, Belgrade, Serbia., Özdemir GN; Pediatric Hematology Department, Istinye University, Istanbul, Turkey., Ay Y; University of Health Sciences Kartal Health Application and Research Center, Pediatric Hematology and Oncology Clinic, Istanbul, Turkey., Makris M; Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, United Kingdom., Lockley C; Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, United Kingdom., Mumford A; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Harvey A; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Austin S; Department of Haematology, Guys and St Thomas' NHS Foundation Trust, London, United Kingdom., Shapiro A; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN., Williamson A; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN., McGuinn C; Indiana Hemophilia and Thrombosis Center, Indianapolis, IN., Goldberg I; Division of Pediatric Hematology Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, NY., De Moerloose P; Division of Angiology and Hemostasis, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland., Peyvandi F; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy.

Publikováno v: Blood advances [Blood Adv] 2024 Mar 26; Vol. 8 (6), pp. 1392-1404.

Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A.

Autor: Agosti P; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione Luigi Villa, Milan, Italy.; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy., Siboni SM; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy., Scardo S; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy., Torri A; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy., Gualtierotti R; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione Luigi Villa, Milan, Italy.; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy., Peyvandi F; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione Luigi Villa, Milan, Italy.; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.

Publikováno v: Blood advances [Blood Adv] 2023 Dec 12; Vol. 7 (23), pp. 7209-7215.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2- early breast cancer in the United States.

Autor: Brown J; Eli Lilly and Company Limited, 8 Arlington Square West, Downshire Way, Bracknell, RG12 1PU, UK. brown_jacqueline_dr@lilly.com., Scardo S; Eli Lilly and Company, Indianapolis, IN, USA., Method M; Eli Lilly and Company, Indianapolis, IN, USA., Schlauch D; Genospace, Boston, MA, USA., Misch A; Genospace, Boston, MA, USA., Picard S; Genospace, Boston, MA, USA., Hamilton E; Sarah Cannon, Nashville, TN, USA.; Tennessee Oncology, Nashville, TN, USA., Jones S; Sarah Cannon, Nashville, TN, USA., Burris H; Sarah Cannon, Nashville, TN, USA.; Tennessee Oncology, Nashville, TN, USA., Spigel D; Sarah Cannon, Nashville, TN, USA.; Tennessee Oncology, Nashville, TN, USA.

Publikováno v: BMC cancer [BMC Cancer] 2022 May 06; Vol. 22 (1), pp. 502. Date of Electronic Publication: 2022 May 06.